• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

如何在经济评估中估算生产力成本。

How to estimate productivity costs in economic evaluations.

作者信息

Krol Marieke, Brouwer Werner

机构信息

Department of Health Policy and Management, Erasmus University, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands,

出版信息

Pharmacoeconomics. 2014 Apr;32(4):335-44. doi: 10.1007/s40273-014-0132-3.

DOI:10.1007/s40273-014-0132-3
PMID:24504850
Abstract

Productivity costs are frequently omitted from economic evaluations, despite their often strong impact on cost-effectiveness outcomes. This neglect may be partly explained by the lack of standardization regarding the methodology of estimating productivity costs. This paper aims to contribute to standardization of productivity cost methodology by offering practical guidance on how to estimate productivity costs in economic evaluations. The paper discusses the identification, measurement and valuation of productivity losses. It is recommended to include not only productivity losses related to absenteeism from and reduced productivity at paid work, but also those related to unpaid work. Hence, it is recommended to use a measurement instrument including questions about both paid and unpaid productivity, such as the iMTA Productivity Cost Questionnaire (iPCQ) or the Valuation of Lost Productivity (VOLP). We indicate how to apply the friction cost and the human capital approach and give practical guidance on deriving final cost estimates.

摘要

尽管生产力成本往往对成本效益结果有很大影响,但在经济评估中却常常被忽略。这种忽视部分原因可能是在估算生产力成本的方法上缺乏标准化。本文旨在通过提供关于如何在经济评估中估算生产力成本的实用指南,为生产力成本方法的标准化做出贡献。本文讨论了生产力损失的识别、测量和估值。建议不仅包括与带薪工作缺勤和生产力降低相关的生产力损失,还包括与无薪工作相关的损失。因此,建议使用一种测量工具,包括有关带薪和无薪生产力的问题,如iMTA生产力成本问卷(iPCQ)或生产力损失估值(VOLP)。我们指出如何应用摩擦成本和人力资本方法,并为得出最终成本估算提供实用指南。

相似文献

1
How to estimate productivity costs in economic evaluations.如何在经济评估中估算生产力成本。
Pharmacoeconomics. 2014 Apr;32(4):335-44. doi: 10.1007/s40273-014-0132-3.
2
The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses.iMTA生产力成本问卷:一种用于测量和评估与健康相关的生产力损失的标准化工具。
Value Health. 2015 Sep;18(6):753-8. doi: 10.1016/j.jval.2015.05.009. Epub 2015 Aug 20.
3
Productivity costs in economic evaluations: past, present, future.经济评估中的生产力成本:过去、现在、未来。
Pharmacoeconomics. 2013 Jul;31(7):537-49. doi: 10.1007/s40273-013-0056-3.
4
Measurement Instruments of Productivity Loss of Paid and Unpaid Work: A Systematic Review and Assessment of Suitability for Health Economic Evaluations From a Societal Perspective.有偿和无偿工作生产力损失的测量工具:从社会角度对健康经济评估适用性的系统评价与评估
Value Health. 2021 Nov;24(11):1686-1699. doi: 10.1016/j.jval.2021.05.002. Epub 2021 Sep 17.
5
A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs.一个显著的差异?在昂贵药物的经济评估中与有偿和无偿工作相关的生产力成本。
Eur J Health Econ. 2016 May;17(4):391-402. doi: 10.1007/s10198-015-0685-x. Epub 2015 Apr 16.
6
The transferability of valuing lost productivity across jurisdictions. differences between national pharmacoeconomic guidelines.在司法管辖区之间转移评估损失生产力的价值。国家药物经济学指南之间的差异。
Value Health. 2010 Aug;13(5):519-27. doi: 10.1111/j.1524-4733.2010.00699.x.
7
Variation in the methodological approach to productivity cost valuation: the case of prostate cancer.生产力成本评估方法的变化:以前列腺癌为例。
Eur J Health Econ. 2019 Dec;20(9):1399-1408. doi: 10.1007/s10198-019-01098-3. Epub 2019 Aug 23.
8
Valuing productivity costs using the friction-cost approach: Estimating friction-period estimates by occupational classifications for the UK.使用摩擦成本法评估生产力成本:按英国职业分类估算摩擦期估计值。
Health Econ. 2017 Dec;26(12):1862-1868. doi: 10.1002/hec.3513. Epub 2017 Apr 27.
9
Economic evaluations of occupational health interventions from a company's perspective: a systematic review of methods to estimate the cost of health-related productivity loss.从企业角度评估职业健康干预措施的经济学评价:估算与健康相关的生产力损失成本的方法系统评价。
J Occup Rehabil. 2011 Mar;21(1):90-9. doi: 10.1007/s10926-010-9258-0.
10
Productivity Losses Associated with Head and Neck Cancer Using the Human Capital and Friction Cost Approaches.使用人力资本法和摩擦成本法评估头颈癌导致的生产力损失
Appl Health Econ Health Policy. 2015 Aug;13(4):359-67. doi: 10.1007/s40258-015-0155-8.

引用本文的文献

1
Disease burden from tobacco consumption in Peru and the projected effect of strengthening control measures: a modeling study.秘鲁烟草消费导致的疾病负担及加强控制措施的预期效果:一项建模研究。
Rev Peru Med Exp Salud Publica. 2025 Aug 25;42(2):126-137. doi: 10.17843/rpmesp.2025.422.14338.
2
Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis.美国裸盖菇素辅助治疗难治性抑郁症:基于模型的成本效益分析
Transl Psychiatry. 2025 Aug 29;15(1):330. doi: 10.1038/s41398-025-03556-4.
3
Prevalence and Associated Factors of Work-Related Spinal Pain Among Bank Workers in Harar, Eastern Ethiopia: A Cross-Sectional Study.

本文引用的文献

1
A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs.一个显著的差异?在昂贵药物的经济评估中与有偿和无偿工作相关的生产力成本。
Eur J Health Econ. 2016 May;17(4):391-402. doi: 10.1007/s10198-015-0685-x. Epub 2015 Apr 16.
2
How to include informal care in economic evaluations.如何将非正规护理纳入经济评价。
Pharmacoeconomics. 2013 Dec;31(12):1105-19. doi: 10.1007/s40273-013-0104-z.
3
Predicting productivity based on EQ-5D: an explorative study.基于EQ-5D预测生产力:一项探索性研究。
埃塞俄比亚东部哈勒尔银行工作人员工作相关脊柱疼痛的患病率及相关因素:一项横断面研究
SAGE Open Nurs. 2025 Aug 21;11:23779608251371100. doi: 10.1177/23779608251371100. eCollection 2025 Jan-Dec.
4
Non-medical costs incurred by critically ill patients with dengue, sepsis and tetanus within a major referral hospital in Southern Vietnam: a cost of illness study.越南南部一家大型转诊医院中登革热、败血症和破伤风重症患者的非医疗费用:一项疾病成本研究。
BMJ Public Health. 2025 Aug 20;3(2):e002169. doi: 10.1136/bmjph-2024-002169. eCollection 2025.
5
Cost-Effectiveness of Treatments for Diabetic Macular Edema: Simulated Bevacizumab-First Step Therapy Versus Real-World Practice.糖尿病性黄斑水肿治疗的成本效益:模拟的贝伐单抗初始治疗与实际临床实践对比
J Vitreoretin Dis. 2025 Aug 11:24741264251359888. doi: 10.1177/24741264251359888.
6
Health economic outcomes and national economic impacts associated with Long COVID in England and Scotland.与英格兰和苏格兰的长期新冠相关的健康经济结果及国家经济影响。
Eur J Health Econ. 2025 Jul 9. doi: 10.1007/s10198-025-01788-1.
7
A vein bypass first versus a best endovascular treatment first revascularization strategy for patients with chronic limb-threatening ischaemia who require an infra-popliteal, with or without an additional more proximal infra-inguinal, revascularization procedure to restore limb perfusion: the BASIL-2 within-trial health economic analysis.对于需要进行腘下(无论是否伴有额外的更靠近侧的腹股沟下)血管重建手术以恢复肢体灌注的慢性肢体威胁性缺血患者,采用先进行静脉搭桥术与先进行最佳血管内治疗的血管重建策略对比:BASIL-2试验内健康经济分析
Br J Surg. 2025 May 31;112(6). doi: 10.1093/bjs/znaf119.
8
A cost analysis of reductions in work productivity for MG patients and their caregivers by symptom severity.根据症状严重程度对重症肌无力患者及其照料者工作生产力降低情况进行的成本分析。
Front Public Health. 2025 Apr 25;13:1538789. doi: 10.3389/fpubh.2025.1538789. eCollection 2025.
9
Bringing malaria diagnosis and treatment closer to the people: economic rationale for expanding malaria community case management to all ages in a rural district in Madagascar.让疟疾诊断和治疗更贴近民众:在马达加斯加一个农村地区将疟疾社区病例管理扩展至所有年龄段的经济合理性
Malar J. 2025 May 4;24(1):141. doi: 10.1186/s12936-025-05381-y.
10
Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study.经济评估中估计生产力损失方法的考察:以食源性疾病为例
Pharmacoeconomics. 2025 Apr;43(4):453-467. doi: 10.1007/s40273-024-01458-9. Epub 2025 Jan 4.
Eur J Health Econ. 2014 Jun;15(5):465-75. doi: 10.1007/s10198-013-0487-y. Epub 2013 Jun 13.
4
Productivity costs in economic evaluations: past, present, future.经济评估中的生产力成本:过去、现在、未来。
Pharmacoeconomics. 2013 Jul;31(7):537-49. doi: 10.1007/s40273-013-0056-3.
5
Productivity cost calculations in health economic evaluations: correcting for compensation mechanisms and multiplier effects.健康经济评估中的生产力成本计算:纠正补偿机制和乘数效应。
Soc Sci Med. 2012 Dec;75(11):1981-8. doi: 10.1016/j.socscimed.2012.07.012. Epub 2012 Jul 27.
6
Imputing at-work productivity loss using results of a randomized controlled trial comparing tapentadol extended release and oxycodone controlled release for osteoarthritis pain.使用比较酒石酸布托啡诺透皮贴剂与羟考酮控释片治疗癌痛的随机对照临床试验结果估算工作时生产力损失。
J Occup Environ Med. 2012 Aug;54(8):933-8. doi: 10.1097/JOM.0b013e31825f31a1.
7
Imputing productivity gains from clinical trials.估算临床试验的生产力增益。
J Occup Environ Med. 2012 Jul;54(7):826-33. doi: 10.1097/JOM.0b013e31825b1bd2.
8
Development of a composite questionnaire, the valuation of lost productivity, to value productivity losses: application in rheumatoid arthritis.开发一种综合问卷,即生产力损失估值,用于衡量生产力损失:在类风湿关节炎中的应用。
Value Health. 2012 Jan;15(1):46-54. doi: 10.1016/j.jval.2011.07.009. Epub 2011 Oct 1.
9
Does the EQ-5D reflect lost earnings?EQ-5D 反映了收入损失吗?
Pharmacoeconomics. 2012 Jan;30(1):47-61. doi: 10.2165/11539910-000000000-00000.
10
Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders.生产效率成本是否重要?:将生产效率成本纳入针对抑郁障碍的干预措施的增量成本中会产生何种影响。
Pharmacoeconomics. 2011 Jul;29(7):601-19. doi: 10.2165/11539970-000000000-00000.